(22UA) BioNTech SE - Performance 22.5% in 12m
Compare 22UA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
6.00%
#33 in Group
Rel. Strength
79.83%
#1615 in Universe
Total Return 12m
22.46%
#37 in Group
Total Return 5y
32.69%
#30 in Group
P/E -
(?) Percentile in Group
P/E Forward 7.14
40th Percentile in Group
PEG 0.05
54th Percentile in Group
FCF Yield -2.25%
76th Percentile in Group
12m Total Return: 22UA (22.5%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: 22UA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for 22UA
Total Return (including Dividends) | 22UA | XBI | S&P 500 |
---|---|---|---|
1 Month | 11.80% | -10.94% | -6.73% |
3 Months | -9.14% | -14.92% | -11.93% |
12 Months | 22.46% | -6.46% | 7.24% |
5 Years | 32.69% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | 22UA | XBI | S&P 500 |
1 Month | 0.40% | -52.8% | -63.5% |
3 Months | -90.6% | -92.8% | -90.3% |
12 Months | 52.6% | -32.4% | 60.6% |
5 Years | -47.4% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #19 | 25.5% | 19.9% |
3 Month | #57 | 6.80% | 3.16% |
12 Month | #37 | 30.9% | 14.2% |
5 Years | #26 | 105% | -18.6% |
FAQs
Does 22UA BioNTech SE outperforms the market?
Yes,
over the last 12 months 22UA made 22.46%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months 22UA made -9.14%, while XBI made -14.92%.
Over the last 3 months 22UA made -9.14%, while XBI made -14.92%.
Performance Comparison 22UA vs Indeces and Sectors
22UA vs. Indices 22UA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 14.7% | 18.5% | 5.70% | 15.2% |
US NASDAQ 100 | QQQ | 14.2% | 19.2% | 5.56% | 14.9% |
US Dow Jones Industrial 30 | DIA | 16.7% | 18.7% | 5.08% | 18.0% |
German DAX 40 | DAX | 13.5% | 15.7% | -14.2% | 2.13% |
Shanghai Shenzhen CSI 300 | CSI 300 | 15.3% | 15.2% | 4.55% | 13.3% |
Hongkong Hang Seng | HSI | 12.0% | 15.5% | 1.16% | 5.68% |
India NIFTY 50 | INDA | 12.5% | 9.77% | 2.35% | 19.5% |
Brasil Bovespa | EWZ | 10.4% | 11.3% | 0.65% | 31.2% |
22UA vs. Sectors 22UA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 14.0% | 18.7% | -3.43% | 7.39% |
Consumer Discretionary | XLY | 13.3% | 18.6% | 0.40% | 11.2% |
Consumer Staples | XLP | 14.5% | 8.82% | -2.26% | 11.1% |
Energy | XLE | 14.6% | 24.3% | 7.0% | 35.2% |
Financial | XLF | 14.0% | 16.7% | -3.17% | 4.63% |
Health Care | XLV | 17.0% | 19.6% | 7.92% | 24.9% |
Industrial | XLI | 15.3% | 17.8% | 5.87% | 18.4% |
Materials | XLB | 15.0% | 17.7% | 13.0% | 28.4% |
Real Estate | XLRE | 14.9% | 15.0% | 6.05% | 7.73% |
Technology | XLK | 14.4% | 20.8% | 11.9% | 21.3% |
Utilities | XLU | 14.8% | 11.6% | 2.07% | 0.78% |
Aerospace & Defense | XAR | 16.1% | 15.0% | -3.67% | 0.59% |
Biotech | XBI | 11.3% | 22.7% | 17.1% | 28.9% |
Homebuilder | XHB | 13.2% | 19.9% | 20.5% | 33.0% |
Retail | XRT | 12.8% | 17.2% | 9.14% | 28.8% |